Discover
ABT
Abbott Laboratories
92.18
400 x undefined
300 x undefined
bid
ask
+
1.44
1.59%
350 @ 05:59 AM
92.77 +0.59 (0.64%)
| Ytd | -26.43% | |
| 1y | -32.35% |
91.77
day range
94.00
81.97
52 week range
137.49
| Open | 92.25 | Prev Close | 90.74 | Low | 91.77 | High | 94.00 | Mkt Cap | 160.56B |
| Vol | 13.05M | Avg Vol | 13.15M | EPS | 3.57 | P/E | 25.82 | Forward P/E | 15.21 |
| Beta | 0.62 | Short Ratio | 1.84 | Inst. Own | 82.53% | Dividend | 2.52 | Div Yield | 2.78 |
| Ex Div Date | 07-15 | Earning | 07-16 | 50-d Avg | 88.87 | 200-d Avg | 112.01 | 1yr Est | 116.54 |
| Income Statement | |||
| Total Revenue | 11.16B | ||
| Revenues (USD) | 11.16B | ||
| Cost of Revenue | 4.89B | ||
| Gross Profit | 6.27B | ||
| Operating Expenses | 4.93B | ||
| Research and Development Expense | 767.00M | ||
| Selling, General and Administrative Expense | 3.74B | ||
| Operating Income | 1.35B | ||
| Interest Expense | 174.00M | ||
| Income Tax Expense | 372.00M | ||
| Net Income | 1.08B | ||
| Net Income Common Stock | 1.08B | ||
| Net Income Common Stock (USD) | 1.08B | ||
| Consolidated Income | 1.08B | ||
| Earnings per Basic Share | 0.62 | ||
| Earnings per Basic Share (USD) | 0.62 | ||
| Earnings per Diluted Share | 0.61 | ||
| Dividends per Basic Common Share | 0.63 | ||
| Earning Before Interest & Taxes (EBIT) | 1.62B | ||
| Earning Before Interest & Taxes (USD) | 1.62B | ||
| Weighted Average Shares | 1.74B | ||
| Weighted Average Shares Diluted | 1.75B | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.80B | ||
| Cash and Equivalents (USD) | 6.80B | ||
| Investments | 1.58B | ||
| Investments Current | 492.00M | ||
| Investments Non-Current | 1.09B | ||
| Trade and Non-Trade Receivables | 8.21B | ||
| Current Assets | 25.51B | ||
| Property, Plant & Equipment Net | 12.38B | ||
| Total Assets | 110.43B | ||
| Debt Current | 4.41B | ||
| Total Debt | 34.05B | ||
| Current Liabilities | 18.38B | ||
| Debt Non-Current | 29.64B | ||
| Total Liabilities | 57.73B | ||
| Accumulated Retained Earnings (Deficit) | 49.96B | ||
| Accumulated Other Comprehensive Income | -6.31B | ||
| Shareholders Equity | 52.70B | ||
| Shareholders Equity (USD) | 52.70B | ||
| Assets Non-Current | 84.92B | ||
| Total Debt (USD) | 34.05B | ||
| Goodwill and Intangible Assets | 53.10B | ||
| Inventory | 6.99B | ||
| Liabilities Non-Current | 39.35B | ||
| Trade and Non-Trade Payables | 4.68B | ||
| Tax Assets | 18.36B | ||
| Tax Liabilities | 598.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 803.00M | ||
| Net Cash Flow from Financing | 17.31B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.72B | ||
| Capital Expenditure | -399.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -19.80B | ||
| Issuance (Purchase) of Equity Shares | -64.00M | ||
| Issuance (Repayment) of Debt Securities | 18.48B | ||
| Payment of Dividends & Other Cash Distributions | -1.10B | ||
| Net Cash Flow from Investing | -20.32B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -161.00M | ||
| Net Cash Flow from Operations | 1.32B | ||
| Effect of Exchange Rate Changes on Cash | -23.00M | ||
| Share Based Compensation | 317.00M | ||